ConductScience.org, home

Paper32808554

Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients.

Jordan AL and 4 others. Mult Scler, 2022. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients. Papers, record 32808554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32808554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients.
PubMed
Journal
Mult Scler
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
5.77
iCite
Revised in PubMed
2022-01-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jordan ALAllison Lm
2Yang JJenniferhttps://orcid.org/0000-0001-8149-5161
3Fisher CJCaitlyn J
4Racke MKMichael K
5Mao-Draayer YYang

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukoencephalopathy, Progressive MultifocalMajor topic
LymphopeniaMajor topic
Multiple SclerosisMajor topic
Aged
Dimethyl Fumarate
Humans
Immunosuppressive Agents

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
UM1 AI110557NIAID NIH HHSUnited StatesUM1AI110557PubMed and NIHNIH RePORTER
UM1 AI144298NIAID NIH HHSUnited StatesUM1AI144298PubMed and NIHNIH RePORTER

Download CSV of grants

References71

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126843383Reassessing the risk of natalizumab-associated PML.J Neurovirol2016https://conductscience.org/library/papers/26843383PubMed
231675639Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosis.Mult Scler Relat Disord2020https://conductscience.org/library/papers/31675639PubMed
321131916Progressive multifocal leukoencephalopathy and other forms of JC virus disease.Nat Rev Neurol2010https://conductscience.org/library/papers/21131916PubMed
427606353Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate.Neurol Neuroimmunol Neuroinflamm2016https://conductscience.org/library/papers/27606353PubMed
525920452Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.Acta Neuropathol2015https://conductscience.org/library/papers/25920452PubMed
627343070PML during dimethyl fumarate treatment of multiple sclerosis: How does lymphopenia matter?Neurology2016https://conductscience.org/library/papers/27343070PubMed
71310438Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.Clin Microbiol Rev1992https://conductscience.org/library/papers/1310438PubMed
828480794Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count.Mult Scler2018https://conductscience.org/library/papers/28480794PubMed
928989935Pathologic Findings of Chronic PML-IRIS in a Patient with Prolonged PML Survival Following Natalizumab Treatment.J Investig Med High Impact Case Rep2017https://conductscience.org/library/papers/28989935PubMed
1029774781Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients.Mult Scler2018https://conductscience.org/library/papers/29774781PubMed
1122733812Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor κB (NF-κB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signaling.J Biol Chem2012https://conductscience.org/library/papers/22733812PubMed
1225738172Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.Neurol Neuroimmunol Neuroinflamm2015https://conductscience.org/library/papers/25738172PubMed
1320664170Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.J Clin Invest2010https://conductscience.org/library/papers/20664170PubMed
1428958667Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis.J Autoimmun2018https://conductscience.org/library/papers/28958667PubMed
158748293Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals.J Clin Microbiol1996https://conductscience.org/library/papers/8748293PubMed
1624691444Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.J Clin Invest2014https://conductscience.org/library/papers/24691444PubMed
1729456537Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye View.Front Immunol2018https://conductscience.org/library/papers/29456537PubMed
1828491903Dimethyl fumarate alters B-cell memory and cytokine production in MS patients.Ann Clin Transl Neurol2017https://conductscience.org/library/papers/28491903PubMed
199168952Dimethylfumarate is an inhibitor of cytokine-induced E-selectin, VCAM-1, and ICAM-1 expression in human endothelial cells.Biochem Biophys Res Commun1997https://conductscience.org/library/papers/9168952PubMed
2022992073Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.N Engl J Med2012https://conductscience.org/library/papers/22992073PubMed

See all 71 referencesDownload CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
42907929Proportionate and disproportionate reporting of different infectious complications of disease modifying therapy in multiple sclerosis.Neurol Res Pract2026https://conductscience.org/library/papers/42907929PubMed
42168998Viral associations in multiple sclerosis: pathogenetic mechanisms and therapeutic implications.Virol J2026https://conductscience.org/library/papers/42168998PubMed
41627610Dimethyl fumarate as a versatile therapeutic agent: molecular mechanisms and potential clinical applications.Mol Biol Rep2026https://conductscience.org/library/papers/41627610PubMed
41486342Mitochondria as a therapeutic target in neurodegeneration caused by hypoxia and ischemia during the perinatal period.Pharmacol Rep2026https://conductscience.org/library/papers/41486342PubMed
41316372Reprogramming autoimmunity: inducing antigen-specific tolerance via apoptotic mimicry in an experimental model of multiple sclerosis.J Neuroinflammation2025https://conductscience.org/library/papers/41316372PubMed
41116174Dimethyl fumarate reprograms cervical cancer cells to enhance antitumor immunity by activating mtDNA-cGAS-STING pathway.J Biomed Sci2025https://conductscience.org/library/papers/41116174PubMed
41034190Multiple sclerosis: molecular pathogenesis and therapeutic intervention.Signal Transduct Target Ther2025https://conductscience.org/library/papers/41034190PubMed
40832152JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumab.Front Neurol2025https://conductscience.org/library/papers/40832152PubMed
40715945JC Polyomavirus Infection: A Narrative Review.Infect Dis Ther2025https://conductscience.org/library/papers/40715945PubMed
40649894Repurposing Dimethyl Fumarate Targeting Nrf2 to Slow Down the Growth of Areas of Geographic Atrophy.Int J Mol Sci2025https://conductscience.org/library/papers/40649894PubMed
40465056A disproportionality analysis of nervous system adverse events associated with disease-modifying therapies in multiple sclerosis: insights from the FDA adverse event reporting system (FAERS).J Neurol2025https://conductscience.org/library/papers/40465056PubMed
40221354Choosing initial MS therapy; personal, disease, and medication factors.Neurotherapeutics2025https://conductscience.org/library/papers/40221354PubMed
39890857Dimethyl fumarate effects on paraquat-induced hepatotoxicity in mice via anti-oxidative, anti-inflammatory, and anti-apoptotic activities.Sci Rep2025https://conductscience.org/library/papers/39890857PubMed
39767644Analysis of Immunological Memory for John Cunningham Virus in a Mexican Population of Patients with Multiple Sclerosis Under Treatment.Biomedicines2024https://conductscience.org/library/papers/39767644PubMed
39707906De-escalating and discontinuing disease-modifying therapies in multiple sclerosis.Brain2025https://conductscience.org/library/papers/39707906PubMed
39466585Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study.Clin Drug Investig2024https://conductscience.org/library/papers/39466585PubMed
39287981Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis.J Clin Invest2024https://conductscience.org/library/papers/39287981PubMed
39200354Understanding the Complex Dynamics of Immunosenescence in Multiple Sclerosis: From Pathogenesis to Treatment.Biomedicines2024https://conductscience.org/library/papers/39200354PubMed
38999279Basic Susceptibility of Patients with Psoriasis under Systemic Therapy for Respiratory Infections: Data from the German Psoriasis Registry PsoBest.J Clin Med2024https://conductscience.org/library/papers/38999279PubMed
38960947Progressive multifocal leukoencephalopathy in association with siponimod treatment for secondary progressive multiple sclerosis: a case report.J Neurol2024https://conductscience.org/library/papers/38960947PubMed

See all 43 cited byDownload CSV of cited by

Genes25

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCR2729230PubTator's text mininghttps://conductscience.org/library/genes/729230NCBI Gene
CCR31232PubTator's text mininghttps://conductscience.org/library/genes/1232NCBI Gene
CCR51234PubTator's text mininghttps://conductscience.org/library/genes/1234NCBI Gene
CCR61235PubTator's text mininghttps://conductscience.org/library/genes/1235NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD69969PubTator's text mininghttps://conductscience.org/library/genes/969NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CXCR32833PubTator's text mininghttps://conductscience.org/library/genes/2833NCBI Gene
EIF2AK39451PubTator's text mininghttps://conductscience.org/library/genes/9451NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
HCAR2338442PubTator's text mininghttps://conductscience.org/library/genes/338442NCBI Gene
HMOX13162PubTator's text mininghttps://conductscience.org/library/genes/3162NCBI Gene
ICAM13383PubTator's text mininghttps://conductscience.org/library/genes/3383NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL17A3605PubTator's text mininghttps://conductscience.org/library/genes/3605NCBI Gene
ITGA43676PubTator's text mininghttps://conductscience.org/library/genes/3676NCBI Gene
KLRB13820PubTator's text mininghttps://conductscience.org/library/genes/3820NCBI Gene

See all 25 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32808554

GET https://conductscience.org/api/papers/v1/32808554/references?page=2